Is this the new Ozempic? The doctor who believes that peptides therapy could be the key to a longer life - The molecules ...

New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...

“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

The study supports prior research that found the same thing.

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

Heavy drinkers have an increased risk of developing brain lesions associated with memory and thinking problems, a new study ...

Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity ... lowering medications may impact brain health,” study co-author Dr. Catriona ...

Some recent research has suggested that type 2 diabetes and dementia may share some physiological similarities, including ...

Research has found that weight-loss drugs such as Ozempic may help curb addictive ... which is increasingly being recognised as a driver of brain ageing,” said Dr Lewis.